Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Sacchetti

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Autoimmunity Reviews|January 18, 2018
Diagnosis and management of neuromyelitis optica spectrum disorders - An updateAlice Bruscolini, Marta Sacchetti, Maurizio La Cava, et al.
The World Allergy Organization Journal|September 19, 2022
The effect of COVID-19 imposed lockdown on Italian children with Vernal KeratoconjunctivitisMaria Cristina Artesani, Mariacristina Esposito, Marta Sacchetti, et al.
Molecular Vision|September 26, 2007
Natural killer cells in vernal keratoconjunctivitisAlessandro Lambiase, Eduardo Maria Normando, Laura Vitiello, et al.
Current Eye Research|June 21, 2017
Recombinant Human Nerve Growth Factor Treatment Promotes Photoreceptor Survival in the Retinas of Rats with Retinitis PigmentosaMarta Sacchetti, Flavio Mantelli, Maria Luisa Rocco, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 11, 2021
Long-term clinical outcome and satisfaction survey in patients with neurotrophic keratopathy after treatment with cenegermin eye drops or amniotic membrane transplantationMarta Sacchetti, Chiara Komaiha, Alice Bruscolini, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 12, 2013
Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trialMauro P Ferrari, Flavio Mantelli, Marta Sacchetti, et al.
Aging and Disease|March 28, 2025
1953-2023. Seventy Years of the Nerve Growth Factor: A Potential Novel Treatment in Neurological Diseases?Davide Norata, Fioravante Capone, Francesco Motolese, et al.
Autoimmunity Reviews|May 6, 2018
Quality of life and neuropsychiatric disorders in patients with Graves' Orbitopathy: Current conceptsAlice Bruscolini, Marta Sacchetti, Maurizio La Cava, et al.
The Ocular Surface|September 11, 2016
A Two-Week, Randomized, Double-masked Study to Evaluate Safety and Efficacy of Lubricin (150 μg/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed®) in Patients with Moderate Dry Eye DiseaseAlessandro Lambiase, Benjamin D Sullivan, Tannin A Schmidt, et al.
Brain : a Journal of Neurology|October 23, 2025
Profiling cognition and brain metabolism in amyotrophic lateral sclerosis and frontotemporal dementiaFabiola De Marchi, Andrea Baj, Federico Menegon, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Autoimmunity Reviews|January 18, 2018
Diagnosis and management of neuromyelitis optica spectrum disorders - An updateAlice Bruscolini, Marta Sacchetti, Maurizio La Cava, et al.
The World Allergy Organization Journal|September 19, 2022
The effect of COVID-19 imposed lockdown on Italian children with Vernal KeratoconjunctivitisMaria Cristina Artesani, Mariacristina Esposito, Marta Sacchetti, et al.
Molecular Vision|September 26, 2007
Natural killer cells in vernal keratoconjunctivitisAlessandro Lambiase, Eduardo Maria Normando, Laura Vitiello, et al.
Current Eye Research|June 21, 2017
Recombinant Human Nerve Growth Factor Treatment Promotes Photoreceptor Survival in the Retinas of Rats with Retinitis PigmentosaMarta Sacchetti, Flavio Mantelli, Maria Luisa Rocco, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 11, 2021
Long-term clinical outcome and satisfaction survey in patients with neurotrophic keratopathy after treatment with cenegermin eye drops or amniotic membrane transplantationMarta Sacchetti, Chiara Komaiha, Alice Bruscolini, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 12, 2013
Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trialMauro P Ferrari, Flavio Mantelli, Marta Sacchetti, et al.
Aging and Disease|March 28, 2025
1953-2023. Seventy Years of the Nerve Growth Factor: A Potential Novel Treatment in Neurological Diseases?Davide Norata, Fioravante Capone, Francesco Motolese, et al.
Autoimmunity Reviews|May 6, 2018
Quality of life and neuropsychiatric disorders in patients with Graves' Orbitopathy: Current conceptsAlice Bruscolini, Marta Sacchetti, Maurizio La Cava, et al.
The Ocular Surface|September 11, 2016
A Two-Week, Randomized, Double-masked Study to Evaluate Safety and Efficacy of Lubricin (150 μg/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed®) in Patients with Moderate Dry Eye DiseaseAlessandro Lambiase, Benjamin D Sullivan, Tannin A Schmidt, et al.
Brain : a Journal of Neurology|October 23, 2025
Profiling cognition and brain metabolism in amyotrophic lateral sclerosis and frontotemporal dementiaFabiola De Marchi, Andrea Baj, Federico Menegon, et al.
Pageof 9